Prime Medicine, Inc. (NYSE:PRME) Receives $12.67 Average PT from Brokerages

Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been given a consensus recommendation of “Buy” by the eleven ratings firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating […]

Leave a Reply

Your email address will not be published.

Previous post Fund L.P. Forager Sells 597 Shares of Regional Management Corp. (NYSE:RM) Stock
Next post HealthEquity, Inc. (NASDAQ:HQY) Receives Average Recommendation of “Moderate Buy” from Analysts